World health organization global health sector strategy on sexually transmitted infections: an evidence-to-action summary for Colombia

ABSTRACT Curable and incurable sexually transmitted infections (STI) are acquired by hundreds of millions of people worldwide each year. Undiagnosed and untreated STIs cause a range of negative health outcomes including adverse birth outcomes, infertility and other long term sequelae such as cervical cancer. In 2016, the World Health Organization (WHO) launched the Global STI Strategy (20162021). The WHO Global STI Strategy's public health approach focuses on three causative organisms of STIs that need immediate action and for which cost-effective interventions exist: (a) Neisseria gonorrhoeae as a cause of infertility, a risk factor for coinfection with other STIs and because of increasing bacterial resistance to antibiotic treatment, (b) Treponema pallidum given the contribution of syphilis to adverse birth outcomes including stillbirth and neonatal death and (c) Human papillomavirus due to its link to cervical cancer. The range of actions recommended for countries includes: (a) strengthening surveillance, with program monitoring and progress evaluation, (b) STI prevention, (c) early diagnosis of STIs, (d) patient and partner management, and (e) approaches to reach the most vulnerable populations. This summary describes the WHO Global STI Strategy alongside findings from a STI surveillance workshop held in Colombia in May of 2017. Observations related to the Global STI Strategy and findings from the STI estimation workshop are described here for stakeholders in Colombia to consider as they identify opportunities to improve STI services and surveillance.

Saved in:
Bibliographic Details
Main Authors: Taylor,Melanie, Alonso-González,Mónica, Gómez,Bertha, Korenromp,Eline, Broutet,Nathalie
Format: Digital revista
Language:English
Published: Federación Colombiana de Obstetricia y Ginecología 2017
Online Access:http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0034-74342017000300193
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0034-74342017000300193
record_format ojs
spelling oai:scielo:S0034-743420170003001932017-10-30World health organization global health sector strategy on sexually transmitted infections: an evidence-to-action summary for ColombiaTaylor,MelanieAlonso-González,MónicaGómez,BerthaKorenromp,ElineBroutet,Nathalie Colombia syphilis congenital syphilis chlamydia gonorrhoea sexually transmitted infections infertility stillbirth antimicrobial resistance prevention strategy policy public health ABSTRACT Curable and incurable sexually transmitted infections (STI) are acquired by hundreds of millions of people worldwide each year. Undiagnosed and untreated STIs cause a range of negative health outcomes including adverse birth outcomes, infertility and other long term sequelae such as cervical cancer. In 2016, the World Health Organization (WHO) launched the Global STI Strategy (20162021). The WHO Global STI Strategy's public health approach focuses on three causative organisms of STIs that need immediate action and for which cost-effective interventions exist: (a) Neisseria gonorrhoeae as a cause of infertility, a risk factor for coinfection with other STIs and because of increasing bacterial resistance to antibiotic treatment, (b) Treponema pallidum given the contribution of syphilis to adverse birth outcomes including stillbirth and neonatal death and (c) Human papillomavirus due to its link to cervical cancer. The range of actions recommended for countries includes: (a) strengthening surveillance, with program monitoring and progress evaluation, (b) STI prevention, (c) early diagnosis of STIs, (d) patient and partner management, and (e) approaches to reach the most vulnerable populations. This summary describes the WHO Global STI Strategy alongside findings from a STI surveillance workshop held in Colombia in May of 2017. Observations related to the Global STI Strategy and findings from the STI estimation workshop are described here for stakeholders in Colombia to consider as they identify opportunities to improve STI services and surveillance.info:eu-repo/semantics/openAccessFederación Colombiana de Obstetricia y GinecologíaRevista Colombiana de Obstetricia y GinecologíaRevista Colombiana de Obstetricia y Ginecología v.68 n.3 20172017-09-01info:eu-repo/semantics/articletext/htmlhttp://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0034-74342017000300193en10.18597/rcog.3071
institution SCIELO
collection OJS
country Colombia
countrycode CO
component Revista
access En linea
databasecode rev-scielo-co
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Taylor,Melanie
Alonso-González,Mónica
Gómez,Bertha
Korenromp,Eline
Broutet,Nathalie
spellingShingle Taylor,Melanie
Alonso-González,Mónica
Gómez,Bertha
Korenromp,Eline
Broutet,Nathalie
World health organization global health sector strategy on sexually transmitted infections: an evidence-to-action summary for Colombia
author_facet Taylor,Melanie
Alonso-González,Mónica
Gómez,Bertha
Korenromp,Eline
Broutet,Nathalie
author_sort Taylor,Melanie
title World health organization global health sector strategy on sexually transmitted infections: an evidence-to-action summary for Colombia
title_short World health organization global health sector strategy on sexually transmitted infections: an evidence-to-action summary for Colombia
title_full World health organization global health sector strategy on sexually transmitted infections: an evidence-to-action summary for Colombia
title_fullStr World health organization global health sector strategy on sexually transmitted infections: an evidence-to-action summary for Colombia
title_full_unstemmed World health organization global health sector strategy on sexually transmitted infections: an evidence-to-action summary for Colombia
title_sort world health organization global health sector strategy on sexually transmitted infections: an evidence-to-action summary for colombia
description ABSTRACT Curable and incurable sexually transmitted infections (STI) are acquired by hundreds of millions of people worldwide each year. Undiagnosed and untreated STIs cause a range of negative health outcomes including adverse birth outcomes, infertility and other long term sequelae such as cervical cancer. In 2016, the World Health Organization (WHO) launched the Global STI Strategy (20162021). The WHO Global STI Strategy's public health approach focuses on three causative organisms of STIs that need immediate action and for which cost-effective interventions exist: (a) Neisseria gonorrhoeae as a cause of infertility, a risk factor for coinfection with other STIs and because of increasing bacterial resistance to antibiotic treatment, (b) Treponema pallidum given the contribution of syphilis to adverse birth outcomes including stillbirth and neonatal death and (c) Human papillomavirus due to its link to cervical cancer. The range of actions recommended for countries includes: (a) strengthening surveillance, with program monitoring and progress evaluation, (b) STI prevention, (c) early diagnosis of STIs, (d) patient and partner management, and (e) approaches to reach the most vulnerable populations. This summary describes the WHO Global STI Strategy alongside findings from a STI surveillance workshop held in Colombia in May of 2017. Observations related to the Global STI Strategy and findings from the STI estimation workshop are described here for stakeholders in Colombia to consider as they identify opportunities to improve STI services and surveillance.
publisher Federación Colombiana de Obstetricia y Ginecología
publishDate 2017
url http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0034-74342017000300193
work_keys_str_mv AT taylormelanie worldhealthorganizationglobalhealthsectorstrategyonsexuallytransmittedinfectionsanevidencetoactionsummaryforcolombia
AT alonsogonzalezmonica worldhealthorganizationglobalhealthsectorstrategyonsexuallytransmittedinfectionsanevidencetoactionsummaryforcolombia
AT gomezbertha worldhealthorganizationglobalhealthsectorstrategyonsexuallytransmittedinfectionsanevidencetoactionsummaryforcolombia
AT korenrompeline worldhealthorganizationglobalhealthsectorstrategyonsexuallytransmittedinfectionsanevidencetoactionsummaryforcolombia
AT broutetnathalie worldhealthorganizationglobalhealthsectorstrategyonsexuallytransmittedinfectionsanevidencetoactionsummaryforcolombia
_version_ 1755932951155048448